NVE Corporation: Medical-Sensor Innovation Supports A Long-Term Buy
NVE Corporation (NVEC) is rated a long-term Buy due to its proprietary spintronics technology, expanding medical-device market presence, and robust profitability. NVEC's ultraminiature magnetic sensors target implantable medical devices, leveraging strong relationships with manufacturers like Abbott Laboratories and recent manufacturing expansions. FY2026 net profit margin reached 58%, with Q1 FY2027 revenue and net income up 81% and 79% respectively, demonstrating accelerating growth momentum.
NVE Corp Q1 Earnings Surge Y/Y on Strong Sales & New Products
NVEC's Q1 results reflect strong revenue growth, higher earnings, and momentum from new products, robotics and AIoT opportunities.
NVE Corporation (NVEC) Q1 2027 Earnings Call Transcript
NVE Corporation (NVEC) Q1 2027 Earnings Call Transcript
NVE Q1 Earnings Call Highlights
NVE NASDAQ: NVEC reported a sharp increase in revenue and earnings for the quarter ended June 30, 2026, with management citing higher product sales, new products and a stronger semiconductor market as key drivers.
The "Spin" on NVE Corp's Upgrade to Outperform
NVEC appears to be at a key inflection point.
NVEC Earns "Outperform" Rating on Defense Recovery & AIoT Demand
NVE earns an "Outperform" upgrade as defense sales recover, manufacturing expansion concludes, and strong momentum in AIoT, robotics and medical-device markets fuels growth prospects.
NVEC Reports Solid Y/Y Earnings Growth in Q4, Unveils Strong Outlook
NVE reports a 27% increase in Q4 net income, driven by strong product sales and an optimistic outlook for growth in the semiconductor and robotics markets.
NVEC vs. AOSL: Which Small-Cap Chip Stock Is the Better Buy?
NVE Corp's niche model, debt-free balance sheet, and lower valuation give it a risk-adjusted edge over Alpha and Omega despite slower growth prospects.
NVEC's Q3 Earnings Rise 11% Y/Y, Highlight Growth Momentum
NVEC reports strong quarterly results, with revenue and earnings growth driven by higher product sales, contract R&D strength and improving end-market demand.
NVE Corporation (NVEC) Q3 2026 Earnings Call Transcript
NVE Corporation (NVEC) Q3 2026 Earnings Call Transcript
NVE Corp Reports Y/Y Declines in Profit & Revenues in Q2
NVEC's Q2 revenues and profit decline y/y, but rising non-defense sales and new products signal improving growth momentum.
NVE Corporation (NVEC) Q2 2026 Earnings Call Transcript
NVE Corporation (NASDAQ:NVEC ) Q2 2026 Earnings Call October 22, 2025 5:00 PM EDT Company Participants Daniel Baker - CEO, President & Director Daniel Nelson - Accounting Manager & Principal Financial Officer and Controller Peter Eames - Vice President of Advanced Technology Conference Call Participants Jeffrey Bernstein - Cowen Inc. Presentation Daniel Baker CEO, President & Director Good afternoon, and welcome to the NVE Corporation Conference Call for the quarter ended September 30, 2025. The I'm Dan Baker, NVE's President and CEO.
